GLENMARK WEBSITES GLOBAL PRESENCE FOLLOW US | CONTACT US ABOUT US RESPONSIBILITY PRODUCTS INVESTORS CAREERS MEDIA DOW JONES SUSTAINABILITY EMERGING MARKETS INDEX 2021 Glenmark secures its position in the prestigious Dow Jones Sustainability Emerging Markets Index for the fourth consecutive year 1 2 3 4 5 6 Prev Next PRODUCTS Delivering high quality affordable medicines to millions of patients worldwide KNOW MORE RESPONSIBILITY Our commitment towards the environment, the community and our people KNOW MORE INVESTOR CORNER LATEST ANNOUNCEMENTS Glenmark's Q2 FY 2021-22 Results Glenmark's MDA Q2 FY 2021 – 22 Glenmark Pharma reports revenue growth of 6.6% and PAT growth of 10.1% YoY for Q2 FY 2021-22 Glenmark’s Q1 FY 2021-22 Results Glenmark’s MDA Q1 FY 2021 – 22 Glenmark Pharma reports revenue growth of 26% and PAT growth of 21% YoY for Q1 FY 2021-22 KNOW MORE Nov 16, 2021 NEWS ANNOUNCEMENT Glenmark Pharmaceuticals makes it to the prestigious Dow Jones Sustainability Emerging Markets Index for the fourth consecutive year KNOW MORE CAREERS Glenmark is a leading, research–based global pharmaceutical company KNOW MORE X By continuing to browse the site you are agreeing to our use of cookies. For more details refer to our Terms of Use Policy. TERMS OF USE ABOUT US RESPONSIBILITY PRODUCTS INVESTORS CAREERS MEDIA COPYRIGHT© 2021, ALL RIGHTS RESERVED